These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15035283)

  • 1. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.
    Lidar Z; Mardor Y; Jonas T; Pfeffer R; Faibel M; Nass D; Hadani M; Ram Z
    J Neurosurg; 2004 Mar; 100(3):472-9. PubMed ID: 15035283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging.
    Mardor Y; Roth Y; Lidar Z; Jonas T; Pfeffer R; Maier SE; Faibel M; Nass D; Hadani M; Orenstein A; Cohen JS; Ram Z
    Cancer Res; 2001 Jul; 61(13):4971-3. PubMed ID: 11431326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of drug efflux on convection-enhanced paclitaxel delivery to malignant gliomas: technical note.
    Tanner PG; Holtmannspötter M; Tonn JC; Goldbrunner R
    Neurosurgery; 2007 Oct; 61(4):E880-2; discussion E882. PubMed ID: 17986926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of paclitaxel in patients with recurrent malignant glioma.
    Prados MD; Schold SC; Spence AM; Berger MS; McAllister LD; Mehta MP; Gilbert MR; Fulton D; Kuhn J; Lamborn K; Rector DJ; Chang SM
    J Clin Oncol; 1996 Aug; 14(8):2316-21. PubMed ID: 8708723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.
    Parney IF; Kunwar S; McDermott M; Berger M; Prados M; Cha S; Croteau D; Puri RK; Chang SM
    J Neurosurg; 2005 Feb; 102(2):267-75. PubMed ID: 15739554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
    Pöpperl G; Goldbrunner R; Gildehaus FJ; Kreth FW; Tanner P; Holtmannspötter M; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1018-25. PubMed ID: 15877226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma.
    Postma TJ; Heimans JJ; Luykx SA; van Groeningen CJ; Beenen LF; Hoekstra OS; Taphoorn MJ; Zonnenberg BA; Klein M; Vermorken JB
    Ann Oncol; 2000 Apr; 11(4):409-13. PubMed ID: 10847458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated operations for infiltrative low-grade gliomas without intervening therapy.
    Schmidt MH; Berger MS; Lamborn KR; Aldape K; McDermott MW; Prados MD; Chang SM
    J Neurosurg; 2003 Jun; 98(6):1165-9. PubMed ID: 12816258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of GRN1005 in recurrent malignant glioma.
    Drappatz J; Brenner A; Wong ET; Eichler A; Schiff D; Groves MD; Mikkelsen T; Rosenfeld S; Sarantopoulos J; Meyers CA; Fielding RM; Elian K; Wang X; Lawrence B; Shing M; Kelsey S; Castaigne JP; Wen PY
    Clin Cancer Res; 2013 Mar; 19(6):1567-76. PubMed ID: 23349317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated stereotactic radiotherapy boost and weekly paclitaxel in malignant gliomas clinical and pharmacokinetics results.
    Ashamalla H; Zaki B; Mokhtar B; Lewis L; Lavaf A; Nasr H; Colella F; Dosik D; Krishnamurthy M; Saad N; Guriguis A
    Technol Cancer Res Treat; 2007 Jun; 6(3):169-76. PubMed ID: 17535024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study.
    Sanson M; Napolitano M; Yaya R; Keime-Guibert F; Broët P; Hoang-Xuan K; Delattre JY
    J Neurooncol; 2000 Dec; 50(3):245-9. PubMed ID: 11263504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma.
    Weber FW; Floeth F; Asher A; Bucholz R; Berger M; Prados M; Chang S; Bruce J; Hall W; Rainov NG; Westphal M; Warnick RE; Rand RW; Rommell F; Pan H; Hingorani VN; Puri RK
    Acta Neurochir Suppl; 2003; 88():93-103. PubMed ID: 14531567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride.
    Saito R; Sonoda Y; Kumabe T; Nagamatsu K; Watanabe M; Tominaga T
    J Neurosurg Pediatr; 2011 May; 7(5):522-6. PubMed ID: 21529193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
    Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY
    Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury.
    Smith JS; Cha S; Mayo MC; McDermott MW; Parsa AT; Chang SM; Dillon WP; Berger MS
    J Neurosurg; 2005 Sep; 103(3):428-38. PubMed ID: 16235673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.